Sibektan

General characteristics. Structure:

Active agents: 
Танацехол® extract dry (tansies ordinary flowers extract dry) with the maintenance of the sum of flavonoids and fenolkarbonovy acids in terms of лютеолин and absolutely dry matter of 55% – 0,025 g.
 
Силимар® extract dry (thistles spotty fruits extract) with the maintenance of the sum of flavolignan in terms of Silubinum and absolutely dry matter of 65% – 0,030 g.

St. John's Wort extract of the sum of flavonoids, dry with contents, in terms of Rutinum and absolutely dry matter of 8% – 0,025 g.

Birches extract dry with the content of phenolic connections in terms of Rutinum and absolutely dry matter of 5% – 0,020 g.

Excipients: 
lactose (sugar milk), starch potato grade "extra", silicon dioxide colloid (A-380 Aerosil), calcium stearate (calcium stearate), croscarmellose sodium. – enough before receiving a tablet weighing 0,2 g.

Pharmacological properties:

Сибектан® renders hepatoprotective, membrane stabilizing, antioxidant and cholagogue action.

Indications to use:

Сибектан® apply at adults as hepatoprotective cure for chronic persistent hepatitis, chronic cholecystitis, hypomotor dyskinesia of a gall bladder.
Сибектан® apply also in complex therapy of cirrhosis and fatty dystrophy of a liver of alcoholic genesis.

Route of administration and doses:

Sibektan accept inside 2 tablets 4 times a day in 20-40 minutes prior to food. Course of treatment of 20-25 days. If necessary the course of treatment can be continued according to the recommendation of the doctor for 10-15 days.
 

Features of use:

According to clinical trials Sibektan is effective at use in complex treatment of a chronic viral hepatitis In and With with poorly and moderately expressed activity of a disease.

Use in pediatrics:
Children are not recommended to appoint drug aged up to 12 years.

Side effects:

Allergic reactions are possible.

Interaction with other medicines:

Medicinal interaction of drug Sibektan is not described.

Contraindications:

Hypersensitivity to drug components, a cholelithiasis, pregnancy, the lactation period, children's age up to 18 years.

Overdose:

So far cases of overdose are not revealed.

Storage conditions:

In the dry, protected from light place, at a temperature not above 25 °C.
To store in the place, unavailable to children.

Issue conditions:

Without recipe

Packaging:

Tablets.
On 10, 20 or 30 tablets in a blister strip packaging. 1, 2 or 3 blister strip packagings No. 10; 1 either 2 blister strip packagings No. 20, or 1 blister strip packaging No. 30 together with the application instruction are placed in a pack from a cardboard for a retail container.